메뉴 건너뛰기




Volumn 6, Issue 8, 2015, Pages 717-726

Perspective of targeting cancer-associated fibroblasts in melanoma

Author keywords

Cancer associated fibroblasts; Melanoma; Skin cancer; Tumor microenvironment

Indexed keywords

ALPHA INTERFERON; CALVASCULIN; DABRAFENIB; DACARBAZINE; HYALURONIC ACID; IMATINIB; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 8; IPILIMUMAB; MITOGEN ACTIVATED PROTEIN KINASE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; NERVE CELL ADHESION MOLECULE; NILOTINIB; NIVOLUMAB; PEMBROLIZUMAB; PLATELET DERIVED GROWTH FACTOR RECEPTOR; SEPRASE; SUNITINIB; TEMOZOLOMIDE; TRAMETINIB; VASCULOTROPIN; VEMURAFENIB;

EID: 84947758976     PISSN: None     EISSN: 18379664     Source Type: Journal    
DOI: 10.7150/jca.10865     Document Type: Review
Times cited : (98)

References (140)
  • 1
    • 84855692909 scopus 로고    scopus 로고
    • American Cancer Society
    • [Internet] American Cancer Society. What are the key statistics about melanoma skin cancer? http://www.cancer.org/cancer/skincancer-melanoma/detailedguide/melanoma-skin-cancer-key-statistics: American Cancer Society; 2014.
    • (2014) What are the key statistics about melanoma skin cancer?
  • 4
    • 84899490109 scopus 로고    scopus 로고
    • The role of adjuvant radiotherapy in the local management of desmoplastic melanoma
    • Guadagnolo BA, Prieto V, Weber R, Ross MI, Zagars GK. The role of adjuvant radiotherapy in the local management of desmoplastic melanoma. Cancer. 2014; 120: 1361-8.
    • (2014) Cancer , vol.120 , pp. 1361-1368
    • Guadagnolo, B.A.1    Prieto, V.2    Weber, R.3    Ross, M.I.4    Zagars, G.K.5
  • 6
    • 79952613370 scopus 로고    scopus 로고
    • Systematic review of medical treatment in melanoma: current status and future prospects
    • Garbe C, Eigentler TK, Keilholz U, Hauschild A, Kirkwood JM. Systematic review of medical treatment in melanoma: current status and future prospects. The oncologist. 2011; 16: 5-24.
    • (2011) The oncologist , vol.16 , pp. 5-24
    • Garbe, C.1    Eigentler, T.K.2    Keilholz, U.3    Hauschild, A.4    Kirkwood, J.M.5
  • 7
    • 18244365876 scopus 로고    scopus 로고
    • Combination chemotherapy with or without s.c. IL-2 and IFN-alpha: results of a prospectively randomized trial of the Cooperative Advanced Malignant Melanoma Chemoimmunotherapy Group (ACIMM)
    • Atzpodien J, Neuber K, Kamanabrou D, Fluck M, Brocker EB, Neumann C, et al. Combination chemotherapy with or without s.c. IL-2 and IFN-alpha: results of a prospectively randomized trial of the Cooperative Advanced Malignant Melanoma Chemoimmunotherapy Group (ACIMM). British journal of cancer. 2002; 86: 179-84.
    • (2002) British journal of cancer , vol.86 , pp. 179-184
    • Atzpodien, J.1    Neuber, K.2    Kamanabrou, D.3    Fluck, M.4    Brocker, E.B.5    Neumann, C.6
  • 8
    • 0034777045 scopus 로고    scopus 로고
    • The role interferon-alpha in malignant melanoma remains to be defined
    • Eggermont AM. The role interferon-alpha in malignant melanoma remains to be defined. Eur J Cancer. 2001; 37: 2147-53.
    • (2001) Eur J Cancer , vol.37 , pp. 2147-2153
    • Eggermont, A.M.1
  • 9
    • 84947734356 scopus 로고    scopus 로고
    • [Internet] FDA. Ipilimumab. http://www.fda.gov/aboutfda/centersoffices/officeofmedicalproductsandtobacco/cder/ucm248478.htm
    • Ipilimumab
  • 10
    • 84883559055 scopus 로고    scopus 로고
    • Immunotherapy for advanced melanoma: fulfilling the promise
    • Gogas H, Polyzos A, Kirkwood J. Immunotherapy for advanced melanoma: fulfilling the promise. Cancer treatment reviews. 2013; 39: 879-85.
    • (2013) Cancer treatment reviews , vol.39 , pp. 879-885
    • Gogas, H.1    Polyzos, A.2    Kirkwood, J.3
  • 12
    • 84904486880 scopus 로고    scopus 로고
    • [Internet] FDA. Trametinib and Dabrafenib. http://www.fda.gov/drugs/informationondrugs/approveddrugs/ucm381451.htm
    • Trametinib and Dabrafenib
  • 13
    • 84945220721 scopus 로고    scopus 로고
    • [Internet] FDA. Nivolumab. http://www.fda.gov/drugs/informationondrugs/approveddrugs/ucm427807.htm
    • Nivolumab
  • 15
    • 2942533921 scopus 로고    scopus 로고
    • Microarray expression profiling in melanoma reveals a BRAF mutation signature
    • Pavey S, Johansson P, Packer L, Taylor J, Stark M, Pollock PM, et al. Microarray expression profiling in melanoma reveals a BRAF mutation signature. Oncogene. 2004; 23: 4060-7.
    • (2004) Oncogene , vol.23 , pp. 4060-4067
    • Pavey, S.1    Johansson, P.2    Packer, L.3    Taylor, J.4    Stark, M.5    Pollock, P.M.6
  • 18
    • 84872061126 scopus 로고    scopus 로고
    • [Internet] FDA. Vemurafenib. http://www.fda.gov/aboutfda/centersoffices/officeofmedicalproductsandtobacco/cder/ucm268301.htm
    • Vemurafenib
  • 19
    • 84872061126 scopus 로고    scopus 로고
    • [Internet] Canada H. Vemurafenib. http://www.hc-sc.gc.ca/dhp-mps/prodpharma/sbd-smd/drug-med/sbd_smd_2012_zelboraf_148693-eng.php
    • Vemurafenib
    • Canada, H.1
  • 20
    • 84900426582 scopus 로고    scopus 로고
    • Beneficial effects of RAF inhibitor in mutant BRAF splice variant-expressing melanoma
    • Hartsough EJ, Basile KJ, Aplin AE. Beneficial effects of RAF inhibitor in mutant BRAF splice variant-expressing melanoma. Molecular cancer research: MCR. 2014; 12: 795-802.
    • (2014) Molecular cancer research: MCR , vol.12 , pp. 795-802
    • Hartsough, E.J.1    Basile, K.J.2    Aplin, A.E.3
  • 21
    • 84879467934 scopus 로고    scopus 로고
    • Ipilimumab, vemurafenib, dabrafenib, and trametinib: synergistic competitors in the clinical management of BRAF mutant malignant melanoma
    • Luke JJ, Hodi FS. Ipilimumab, vemurafenib, dabrafenib, and trametinib: synergistic competitors in the clinical management of BRAF mutant malignant melanoma. The oncologist. 2013; 18: 717-25.
    • (2013) The oncologist , vol.18 , pp. 717-725
    • Luke, J.J.1    Hodi, F.S.2
  • 22
    • 84947804671 scopus 로고    scopus 로고
    • [Internet] FDA. Dabrafenib. http://www.fda.gov/drugs/informationondrugs/approveddrugs/ucm354477.htm
    • Dabrafenib
  • 23
    • 84947809008 scopus 로고    scopus 로고
    • [Internet] FDA. Trametinib. http://www.fda.gov/drugs/informationondrugs/approveddrugs/ucm354478.htm
    • Trametinib
  • 24
    • 72049115498 scopus 로고    scopus 로고
    • KIT as a Therapeutic Target in Melanoma
    • Garrido MC, Bastian BC. KIT as a Therapeutic Target in Melanoma. J Invest Dermatol. 2010; 130: 20-7.
    • (2010) J Invest Dermatol , vol.130 , pp. 20-27
    • Garrido, M.C.1    Bastian, B.C.2
  • 26
    • 84947792392 scopus 로고    scopus 로고
    • My Cancer Genome
    • [Internet] Lovly C, Sosman J, Pao W. Kit. http://www.mycancergenome.org/content/disease/melanoma/kit/?tab=0 My Cancer Genome
    • Kit
    • Lovly, C.1    Sosman, J.2    Pao, W.3
  • 28
    • 67149101027 scopus 로고    scopus 로고
    • c-KIT signaling as the driving oncogenic event in sub-groups of melanomas
    • Smalley KSM, Sondak VK, Weber JS. c-KIT signaling as the driving oncogenic event in sub-groups of melanomas. Histology and histopathology. 2009; 24: 643-50.
    • (2009) Histology and histopathology , vol.24 , pp. 643-650
    • Smalley, K.S.M.1    Sondak, V.K.2    Weber, J.S.3
  • 31
    • 0035692448 scopus 로고    scopus 로고
    • Drug resistance in melanoma: mechanisms, apoptosis, and new potential therapeutic targets
    • Grossman D, Altieri DC. Drug resistance in melanoma: mechanisms, apoptosis, and new potential therapeutic targets. Cancer metastasis reviews. 2001; 20: 3-11.
    • (2001) Cancer metastasis reviews , vol.20 , pp. 3-11
    • Grossman, D.1    Altieri, D.C.2
  • 33
    • 84865841467 scopus 로고    scopus 로고
    • Chapter Eleven-Intratumoral Heterogeneity as a Therapy Resistance Mechanism: Role of Melanoma Subpopulations
    • Keiran SMS, editor. Academic Press
    • Somasundaram R, Villanueva J, Herlyn M. Chapter Eleven-Intratumoral Heterogeneity as a Therapy Resistance Mechanism: Role of Melanoma Subpopulations. In: Keiran SMS, editor. Advances in Pharmacology. Academic Press; 2012: 335-59.
    • (2012) Advances in Pharmacology , pp. 335-359
    • Somasundaram, R.1    Villanueva, J.2    Herlyn, M.3
  • 34
    • 0036176510 scopus 로고    scopus 로고
    • Mechanisms of cancer drug resistance
    • Gottesman MM. Mechanisms of cancer drug resistance. Annual review of medicine. 2002; 53: 615-27.
    • (2002) Annual review of medicine , vol.53 , pp. 615-627
    • Gottesman, M.M.1
  • 35
    • 46949085582 scopus 로고    scopus 로고
    • Intrinsic and acquired drug resistance in malignant tumors. The main reason for therapeutic failure
    • Lippert TH, Ruoff HJ, Volm M. Intrinsic and acquired drug resistance in malignant tumors. The main reason for therapeutic failure. Arzneimittel-Forschung. 2008; 58: 261-4.
    • (2008) Arzneimittel-Forschung , vol.58 , pp. 261-264
    • Lippert, T.H.1    Ruoff, H.J.2    Volm, M.3
  • 36
    • 84898910635 scopus 로고    scopus 로고
    • Ipilimumab: A First-in-Class T-Cell Potentiator for Metastatic Melanoma
    • Chmielowski B. Ipilimumab: A First-in-Class T-Cell Potentiator for Metastatic Melanoma. Journal of Skin Cancer. 2013; 2013: 8.
    • (2013) Journal of Skin Cancer , vol.2013 , pp. 8
    • Chmielowski, B.1
  • 37
    • 84902825664 scopus 로고    scopus 로고
    • Improved survival with T cell clonotype stability after anti-CTLA-4 treatment in cancer patients
    • Cha E, Klinger M, Hou Y, Cummings C, Ribas A, Faham M, et al. Improved survival with T cell clonotype stability after anti-CTLA-4 treatment in cancer patients. Science translational medicine. 2014; 6: 238-70.
    • (2014) Science translational medicine , vol.6 , pp. 238-270
    • Cha, E.1    Klinger, M.2    Hou, Y.3    Cummings, C.4    Ribas, A.5    Faham, M.6
  • 38
    • 84873728334 scopus 로고    scopus 로고
    • Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance
    • Das Thakur M, Salangsang F, Landman AS, Sellers WR, Pryer NK, Levesque MP, et al. Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance. Nature. 2013; 494: 251-5.
    • (2013) Nature , vol.494 , pp. 251-255
    • Das Thakur, M.1    Salangsang, F.2    Landman, A.S.3    Sellers, W.R.4    Pryer, N.K.5    Levesque, M.P.6
  • 39
    • 84891898344 scopus 로고    scopus 로고
    • Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy
    • Shi H, Hugo W, Kong X, Hong A, Koya RC, Moriceau G, et al. Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy. Cancer discovery. 2014; 4: 80-93.
    • (2014) Cancer discovery , vol.4 , pp. 80-93
    • Shi, H.1    Hugo, W.2    Kong, X.3    Hong, A.4    Koya, R.C.5    Moriceau, G.6
  • 40
    • 84864994126 scopus 로고    scopus 로고
    • Reactivation of mitogen-activated protein kinase (MAPK) pathway by FGF receptor 3 (FGFR3)/Ras mediates resistance to vemurafenib in human B-RAF V600E mutant melanoma
    • Yadav V, Zhang X, Liu J, Estrem S, Li S, Gong XQ, et al. Reactivation of mitogen-activated protein kinase (MAPK) pathway by FGF receptor 3 (FGFR3)/Ras mediates resistance to vemurafenib in human B-RAF V600E mutant melanoma. The Journal of biological chemistry. 2012; 287: 28087-98.
    • (2012) The Journal of biological chemistry , vol.287 , pp. 28087-28098
    • Yadav, V.1    Zhang, X.2    Liu, J.3    Estrem, S.4    Li, S.5    Gong, X.Q.6
  • 42
    • 84864285794 scopus 로고    scopus 로고
    • Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
    • Straussman R, Morikawa T, Shee K, Barzily-Rokni M, Qian ZR, Du J, et al. Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion. Nature. 2012; 487: 500-4.
    • (2012) Nature , vol.487 , pp. 500-504
    • Straussman, R.1    Morikawa, T.2    Shee, K.3    Barzily-Rokni, M.4    Qian, Z.R.5    Du, J.6
  • 43
    • 84890417671 scopus 로고    scopus 로고
    • Severe adverse events from the treatment of advanced melanoma: a systematic review of severe side effects associated with ipilimumab, vemurafenib, interferon alfa-2b, dacarbazine and interleukin-2
    • Ma C, Armstrong AW. Severe adverse events from the treatment of advanced melanoma: a systematic review of severe side effects associated with ipilimumab, vemurafenib, interferon alfa-2b, dacarbazine and interleukin-2. The Journal of dermatological treatment. 2014; 25: 401-8.
    • (2014) The Journal of dermatological treatment , vol.25 , pp. 401-408
    • Ma, C.1    Armstrong, A.W.2
  • 45
    • 39749104201 scopus 로고    scopus 로고
    • Practical guidelines for the management of interferon-alpha-2b side effects in patients receiving adjuvant treatment for melanoma: expert opinion
    • Hauschild A, Gogas H, Tarhini A, Middleton MR, Testori A, Dreno B, et al. Practical guidelines for the management of interferon-alpha-2b side effects in patients receiving adjuvant treatment for melanoma: expert opinion. Cancer. 2008; 112: 982-94.
    • (2008) Cancer , vol.112 , pp. 982-994
    • Hauschild, A.1    Gogas, H.2    Tarhini, A.3    Middleton, M.R.4    Testori, A.5    Dreno, B.6
  • 47
    • 84878451069 scopus 로고    scopus 로고
    • Prospective study of cutaneous side-effects associated with the BRAF inhibitor vemurafenib: a study of 42 patients
    • Boussemart L, Routier E, Mateus C, Opletalova K, Sebille G, Kamsu-Kom N, et al. Prospective study of cutaneous side-effects associated with the BRAF inhibitor vemurafenib: a study of 42 patients. Ann Oncol. 2013; 24: 1691-7.
    • (2013) Ann Oncol , vol.24 , pp. 1691-1697
    • Boussemart, L.1    Routier, E.2    Mateus, C.3    Opletalova, K.4    Sebille, G.5    Kamsu-Kom, N.6
  • 48
    • 72949113024 scopus 로고    scopus 로고
    • Stromal cells and integrins: conforming to the needs of the tumor microenvironment
    • Alphonso A, Alahari SK. Stromal cells and integrins: conforming to the needs of the tumor microenvironment. Neoplasia. 2009; 11: 1264-71.
    • (2009) Neoplasia , vol.11 , pp. 1264-1271
    • Alphonso, A.1    Alahari, S.K.2
  • 49
    • 28844444157 scopus 로고    scopus 로고
    • Exploring the tumour environment: cancer-associated fibroblasts as targets in cancer therapy
    • Micke P, Ostman A. Exploring the tumour environment: cancer-associated fibroblasts as targets in cancer therapy. Expert opinion on therapeutic targets. 2005; 9: 1217-33.
    • (2005) Expert opinion on therapeutic targets , vol.9 , pp. 1217-1233
    • Micke, P.1    Ostman, A.2
  • 50
    • 18844428327 scopus 로고    scopus 로고
    • Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion
    • Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell. 2005; 121: 335-48.
    • (2005) Cell , vol.121 , pp. 335-348
    • Orimo, A.1    Gupta, P.B.2    Sgroi, D.C.3    Arenzana-Seisdedos, F.4    Delaunay, T.5    Naeem, R.6
  • 51
    • 77956883321 scopus 로고    scopus 로고
    • Activation of fibroblasts in cancer stroma
    • Rasanen K, Vaheri A. Activation of fibroblasts in cancer stroma. Experimental cell research. 2010; 316: 2713-22.
    • (2010) Experimental cell research , vol.316 , pp. 2713-2722
    • Rasanen, K.1    Vaheri, A.2
  • 53
    • 0033215242 scopus 로고    scopus 로고
    • Carcinoma-associated Fibroblasts Direct Tumor Progression of Initiated Human Prostatic Epithelium
    • Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, Cunha GR. Carcinoma-associated Fibroblasts Direct Tumor Progression of Initiated Human Prostatic Epithelium. Cancer Res. 1999; 59: 5002-11.
    • (1999) Cancer Res , vol.59 , pp. 5002-5011
    • Olumi, A.F.1    Grossfeld, G.D.2    Hayward, S.W.3    Carroll, P.R.4    Tlsty, T.D.5    Cunha, G.R.6
  • 56
    • 80054926267 scopus 로고    scopus 로고
    • Activation of Notch1 signaling in stromal fibroblasts inhibits melanoma growth by upregulating WISP-1
    • Shao H, Cai L, Grichnik JM, Livingstone AS, Velazquez OC, Liu ZJ. Activation of Notch1 signaling in stromal fibroblasts inhibits melanoma growth by upregulating WISP-1. Oncogene. 2011; 30: 4316-26.
    • (2011) Oncogene , vol.30 , pp. 4316-4326
    • Shao, H.1    Cai, L.2    Grichnik, J.M.3    Livingstone, A.S.4    Velazquez, O.C.5    Liu, Z.J.6
  • 57
    • 0035890359 scopus 로고    scopus 로고
    • Transforming growth factor-beta1 increases survival of human melanoma through stroma remodeling
    • Berking C, Takemoto R, Schaider H, Showe L, Satyamoorthy K, Robbins P, et al. Transforming growth factor-beta1 increases survival of human melanoma through stroma remodeling. Cancer Res. 2001; 61: 8306-16.
    • (2001) Cancer Res , vol.61 , pp. 8306-8316
    • Berking, C.1    Takemoto, R.2    Schaider, H.3    Showe, L.4    Satyamoorthy, K.5    Robbins, P.6
  • 59
    • 84901020848 scopus 로고    scopus 로고
    • Cancer-associated fibroblasts as another polarized cell type of the tumor microenvironment
    • Augsten M. Cancer-associated fibroblasts as another polarized cell type of the tumor microenvironment. Frontiers in oncology. 2014; 4: 63
    • (2014) Frontiers in oncology , vol.4 , pp. 63
    • Augsten, M.1
  • 61
    • 66849093706 scopus 로고    scopus 로고
    • On the origin of cancer-associated fibroblasts
    • Anderberg C, Pietras K. On the origin of cancer-associated fibroblasts. Cell Cycle. 2009; 8: 1461-2.
    • (2009) Cell Cycle , vol.8 , pp. 1461-1462
    • Anderberg, C.1    Pietras, K.2
  • 62
    • 75849159205 scopus 로고    scopus 로고
    • Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression
    • Shimoda M, Mellody KT, Orimo A. Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression. Seminars in cell & developmental biology. 2010; 21: 19-25.
    • (2010) Seminars in cell & developmental biology , vol.21 , pp. 19-25
    • Shimoda, M.1    Mellody, K.T.2    Orimo, A.3
  • 63
    • 84857640591 scopus 로고    scopus 로고
    • Cancer associated fibroblasts: the dark side of the coin
    • Cirri P, Chiarugi P. Cancer associated fibroblasts: the dark side of the coin. American journal of cancer research. 2011; 1: 482-97.
    • (2011) American journal of cancer research , vol.1 , pp. 482-497
    • Cirri, P.1    Chiarugi, P.2
  • 64
    • 79952392467 scopus 로고    scopus 로고
    • Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression
    • Bissell MJ, Hines WC. Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nat Med. 2011; 17: 320-9.
    • (2011) Nat Med , vol.17 , pp. 320-329
    • Bissell, M.J.1    Hines, W.C.2
  • 66
    • 23744452875 scopus 로고    scopus 로고
    • Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP-and HGF-mediated signaling networks
    • Cheng N, Bhowmick NA, Chytil A, Gorksa AE, Brown KA, Muraoka R, et al. Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP-and HGF-mediated signaling networks. Oncogene. 2005; 24: 5053-68.
    • (2005) Oncogene , vol.24 , pp. 5053-5068
    • Cheng, N.1    Bhowmick, N.A.2    Chytil, A.3    Gorksa, A.E.4    Brown, K.A.5    Muraoka, R.6
  • 67
  • 69
    • 34447276000 scopus 로고    scopus 로고
    • Tumor microenvironment: the role of the tumor stroma in cancer
    • Li H, Fan X, Houghton J. Tumor microenvironment: the role of the tumor stroma in cancer. Journal of cellular biochemistry. 2007; 101: 805-15.
    • (2007) Journal of cellular biochemistry , vol.101 , pp. 805-815
    • Li, H.1    Fan, X.2    Houghton, J.3
  • 70
    • 3042697038 scopus 로고    scopus 로고
    • Hyaluronan: from extracellular glue to pericellular cue
    • Toole BP. Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer. 2004; 4: 528-39.
    • (2004) Nat Rev Cancer , vol.4 , pp. 528-539
    • Toole, B.P.1
  • 71
    • 50149105712 scopus 로고    scopus 로고
    • Impact of the hyaluronan-rich tumor microenvironment on cancer initiation and progression
    • Itano N, Zhuo L, Kimata K. Impact of the hyaluronan-rich tumor microenvironment on cancer initiation and progression. Cancer science. 2008; 99: 1720-5.
    • (2008) Cancer science , vol.99 , pp. 1720-1725
    • Itano, N.1    Zhuo, L.2    Kimata, K.3
  • 73
    • 20144385541 scopus 로고    scopus 로고
    • Regulation of MDR1 expression and drug resistance by a positive feedback loop involving hyaluronan, phosphoinositide 3-kinase, and ErbB2
    • Misra S, Ghatak S, Toole BP. Regulation of MDR1 expression and drug resistance by a positive feedback loop involving hyaluronan, phosphoinositide 3-kinase, and ErbB2. The Journal of biological chemistry. 2005; 280: 20310-5.
    • (2005) The Journal of biological chemistry , vol.280 , pp. 20310-20315
    • Misra, S.1    Ghatak, S.2    Toole, B.P.3
  • 75
    • 23444445895 scopus 로고    scopus 로고
    • Hyaluronan metabolism: a major paradox in cancer biology
    • Stern R. Hyaluronan metabolism: a major paradox in cancer biology. Pathologie-biologie. 2005; 53: 372-82.
    • (2005) Pathologie-biologie , vol.53 , pp. 372-382
    • Stern, R.1
  • 76
    • 84875945044 scopus 로고    scopus 로고
    • Biological Characteristics and Genetic Heterogeneity between Carcinoma-Associated Fibroblasts and Their Paired Normal Fibroblasts in Human Breast Cancer
    • Peng QL, Zhao LY, Hou YX, Sun Y, Wang LY, Luo HJ, et al. Biological Characteristics and Genetic Heterogeneity between Carcinoma-Associated Fibroblasts and Their Paired Normal Fibroblasts in Human Breast Cancer. Plos One. 2013; 8.
    • (2013) Plos One , pp. 8
    • Peng, Q.L.1    Zhao, L.Y.2    Hou, Y.X.3    Sun, Y.4    Wang, L.Y.5    Luo, H.J.6
  • 77
    • 84892917277 scopus 로고    scopus 로고
    • Interleukin-6 released by colon cancer-associated fibroblasts is critical for tumour angiogenesis: anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour-stroma interaction
    • Nagasaki T, Hara M, Nakanishi H, Takahashi H, Sato M, Takeyama H. Interleukin-6 released by colon cancer-associated fibroblasts is critical for tumour angiogenesis: anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour-stroma interaction. British journal of cancer. 2014; 110: 469-78.
    • (2014) British journal of cancer , vol.110 , pp. 469-478
    • Nagasaki, T.1    Hara, M.2    Nakanishi, H.3    Takahashi, H.4    Sato, M.5    Takeyama, H.6
  • 78
    • 69449095344 scopus 로고    scopus 로고
    • Differential influence of normal and cancer-associated fibroblasts on the growth of human epithelial cells in an in vitro cocultivation model of prostate cancer
    • Paland N, Kamer I, Kogan-Sakin I, Madar S, Goldfinger N, Rotter V. Differential influence of normal and cancer-associated fibroblasts on the growth of human epithelial cells in an in vitro cocultivation model of prostate cancer. Molecular cancer research: MCR. 2009; 7: 1212-23.
    • (2009) Molecular cancer research: MCR , vol.7 , pp. 1212-1223
    • Paland, N.1    Kamer, I.2    Kogan-Sakin, I.3    Madar, S.4    Goldfinger, N.5    Rotter, V.6
  • 79
    • 49749144117 scopus 로고    scopus 로고
    • Human breast cancer-associated fibroblasts (CAFs) show caveolin-1 downregulation and RB tumor suppressor functional inactivation-Implications for the response to hormonal therapy
    • Mercier I, Casimiro MC, Wang CG, Rosenberg AL, Quong J, Minkeu A, et al. Human breast cancer-associated fibroblasts (CAFs) show caveolin-1 downregulation and RB tumor suppressor functional inactivation-Implications for the response to hormonal therapy. Cancer Biology & Therapy. 2008; 7: 1212-25.
    • (2008) Cancer Biology & Therapy , vol.7 , pp. 1212-1225
    • Mercier, I.1    Casimiro, M.C.2    Wang, C.G.3    Rosenberg, A.L.4    Quong, J.5    Minkeu, A.6
  • 80
    • 84867095073 scopus 로고    scopus 로고
    • The architecture of fibroblast monolayers of different origin differentially influences tumor cell growth
    • Flaberg E, Guven H, Savchenko A, Pavlova T, Kashuba V, Szekely L, et al. The architecture of fibroblast monolayers of different origin differentially influences tumor cell growth. International Journal of Cancer. 2012; 131: 2274-83.
    • (2012) International Journal of Cancer , vol.131 , pp. 2274-2283
    • Flaberg, E.1    Guven, H.2    Savchenko, A.3    Pavlova, T.4    Kashuba, V.5    Szekely, L.6
  • 81
    • 84900319246 scopus 로고    scopus 로고
    • [Carcinoma-associated fibroblasts in cancer: the great escape]
    • Albrengues J, Meneguzzi G, Gaggioli C. [Carcinoma-associated fibroblasts in cancer: the great escape]. Med Sci (Paris). 2014; 30: 391-7.
    • (2014) Med Sci (Paris) , vol.30 , pp. 391-397
    • Albrengues, J.1    Meneguzzi, G.2    Gaggioli, C.3
  • 83
    • 0033105730 scopus 로고    scopus 로고
    • Melanoma cell-derived factor stimulation of fibroblast glycosaminoglycan synthesis-the role of platelet-derived growth factor
    • Godden JL, Edward M, MacKie RM. Melanoma cell-derived factor stimulation of fibroblast glycosaminoglycan synthesis-the role of platelet-derived growth factor. Eur J Cancer. 1999; 35: 473-80.
    • (1999) Eur J Cancer , vol.35 , pp. 473-480
    • Godden, J.L.1    Edward, M.2    MacKie, R.M.3
  • 85
    • 84885014865 scopus 로고    scopus 로고
    • Tumor-stromal interactions with direct cell contacts enhance motility of non-small cell lung cancer cells through the hedgehog signaling pathway
    • Choe C, Shin YS, Kim SH, Jeon MJ, Choi SJ, Lee J, et al. Tumor-stromal interactions with direct cell contacts enhance motility of non-small cell lung cancer cells through the hedgehog signaling pathway. Anticancer research. 2013; 33: 3715-23.
    • (2013) Anticancer research , vol.33 , pp. 3715-3723
    • Choe, C.1    Shin, Y.S.2    Kim, S.H.3    Jeon, M.J.4    Choi, S.J.5    Lee, J.6
  • 86
    • 0033838767 scopus 로고    scopus 로고
    • E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors
    • Hsu MY, Meier FE, Nesbit M, Hsu JY, Van Belle P, Elder DE, et al. E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors. The American journal of pathology. 2000; 156: 1515-25.
    • (2000) The American journal of pathology , vol.156 , pp. 1515-1525
    • Hsu, M.Y.1    Meier, F.E.2    Nesbit, M.3    Hsu, J.Y.4    Van Belle, P.5    Elder, D.E.6
  • 88
    • 0035328628 scopus 로고    scopus 로고
    • N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells
    • Li G, Satyamoorthy K, Herlyn M. N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells. Cancer Res. 2001; 61: 3819-25.
    • (2001) Cancer Res , vol.61 , pp. 3819-3825
    • Li, G.1    Satyamoorthy, K.2    Herlyn, M.3
  • 89
    • 84883343415 scopus 로고    scopus 로고
    • E-to N-cadherin switch in melanoma is associated with decreased expression of phosphatase and tensin homolog and cancer progression
    • Lade-Keller J, Riber-Hansen R, Guldberg P, Schmidt H, Hamilton-Dutoit SJ, Steiniche T. E-to N-cadherin switch in melanoma is associated with decreased expression of phosphatase and tensin homolog and cancer progression. Brit J Dermatol. 2013; 169: 618-28.
    • (2013) Brit J Dermatol , vol.169 , pp. 618-628
    • Lade-Keller, J.1    Riber-Hansen, R.2    Guldberg, P.3    Schmidt, H.4    Hamilton-Dutoit, S.J.5    Steiniche, T.6
  • 90
    • 84861594264 scopus 로고    scopus 로고
    • Cadherin switch from E-to N-cadherin in melanoma progression is regulated by the PI3K/PTEN pathway through Twist and Snail
    • Hao L, Ha JR, Kuzel P, Garcia E, Persad S. Cadherin switch from E-to N-cadherin in melanoma progression is regulated by the PI3K/PTEN pathway through Twist and Snail. Brit J Dermatol. 2012; 166: 1184-97.
    • (2012) Brit J Dermatol , vol.166 , pp. 1184-1197
    • Hao, L.1    Ha, J.R.2    Kuzel, P.3    Garcia, E.4    Persad, S.5
  • 91
    • 84891757812 scopus 로고    scopus 로고
    • CD44 expressed on cancer-associated fibroblasts is a functional molecule supporting the stemness and drug resistance of malignant cancer cells in the tumor microenvironment
    • Kinugasa Y, Matsui T, Takakura N. CD44 expressed on cancer-associated fibroblasts is a functional molecule supporting the stemness and drug resistance of malignant cancer cells in the tumor microenvironment. Stem Cells. 2014; 32: 145-56.
    • (2014) Stem Cells , vol.32 , pp. 145-156
    • Kinugasa, Y.1    Matsui, T.2    Takakura, N.3
  • 92
    • 84883470829 scopus 로고    scopus 로고
    • Mesenchymal CD44 Expression Contributes to the Acquisition of an Activated Fibroblast Phenotype via TWIST Activation in the Tumor Microenvironment
    • Spaeth EL, Labaff AM, Toole BP, Klopp A, Andreeff M, Marini FC. Mesenchymal CD44 Expression Contributes to the Acquisition of an Activated Fibroblast Phenotype via TWIST Activation in the Tumor Microenvironment. Cancer Res. 2013; 73: 5347-59.
    • (2013) Cancer Res , vol.73 , pp. 5347-5359
    • Spaeth, E.L.1    Labaff, A.M.2    Toole, B.P.3    Klopp, A.4    Andreeff, M.5    Marini, F.C.6
  • 93
    • 84947806628 scopus 로고    scopus 로고
    • Cancer-associated fibroblasts (CAF) expressing CD44 high increased the aggressiveness of cancer cells. AACR International Conference on Translational Cancer Medicine
    • Shim S, Hah J, Sung M. Cancer-associated fibroblasts (CAF) expressing CD44 high increased the aggressiveness of cancer cells. AACR International Conference on Translational Cancer Medicine. San Francisco, CA: Clin Cancer Res 2010; 2010: A6.
    • (2010) San Francisco, CA: Clin Cancer Res , vol.2010 , pp. A6
    • Shim, S.1    Hah, J.2    Sung, M.3
  • 94
    • 84859949610 scopus 로고    scopus 로고
    • The extracellular matrix: a dynamic niche in cancer progression
    • Lu P, Weaver VM, Werb Z. The extracellular matrix: a dynamic niche in cancer progression. The Journal of cell biology. 2012; 196: 395-406.
    • (2012) The Journal of cell biology , vol.196 , pp. 395-406
    • Lu, P.1    Weaver, V.M.2    Werb, Z.3
  • 95
    • 0343415583 scopus 로고    scopus 로고
    • Fibroblasts surrounding melanoma express elevated levels of matrix metalloproteinase-1 (MMP-1) and intercellular adhesion molecule-1 (ICAM-1) in vitro
    • Wandel E, Grasshoff A, Mittag M, Haustein UF, Saalbach A. Fibroblasts surrounding melanoma express elevated levels of matrix metalloproteinase-1 (MMP-1) and intercellular adhesion molecule-1 (ICAM-1) in vitro. Experimental dermatology. 2000; 9: 34-41.
    • (2000) Experimental dermatology , vol.9 , pp. 34-41
    • Wandel, E.1    Grasshoff, A.2    Mittag, M.3    Haustein, U.F.4    Saalbach, A.5
  • 96
    • 0344442797 scopus 로고    scopus 로고
    • Influence of cultured dermal fibroblasts on human melanoma cell proliferation, matrix metalloproteinase-2 (MMP-2) expression and invasion in vitro
    • Ntayi C, Hornebeck W, Bernard P. Influence of cultured dermal fibroblasts on human melanoma cell proliferation, matrix metalloproteinase-2 (MMP-2) expression and invasion in vitro. Archives of dermatological research. 2003; 295: 236-41.
    • (2003) Archives of dermatological research , vol.295 , pp. 236-241
    • Ntayi, C.1    Hornebeck, W.2    Bernard, P.3
  • 97
    • 15044364789 scopus 로고    scopus 로고
    • High invasive melanoma cells induce matrix metalloproteinase-1 synthesis in fibroblasts by interleukin-1alpha and basic fibroblast growth factor-mediated mechanisms
    • Loffek S, Zigrino P, Angel P, Anwald B, Krieg T, Mauch C. High invasive melanoma cells induce matrix metalloproteinase-1 synthesis in fibroblasts by interleukin-1alpha and basic fibroblast growth factor-mediated mechanisms. J Invest Dermatol. 2005; 124: 638-43.
    • (2005) J Invest Dermatol , vol.124 , pp. 638-643
    • Loffek, S.1    Zigrino, P.2    Angel, P.3    Anwald, B.4    Krieg, T.5    Mauch, C.6
  • 98
    • 84896914323 scopus 로고    scopus 로고
    • Noncanonical activation of Notch1 protein by membrane type 1 matrix metalloproteinase (MT1-MMP) controls melanoma cell proliferation
    • Ma J, Tang X, Wong P, Jacobs B, Borden EC, Bedogni B. Noncanonical activation of Notch1 protein by membrane type 1 matrix metalloproteinase (MT1-MMP) controls melanoma cell proliferation. The Journal of biological chemistry. 2014; 289: 8442-9.
    • (2014) The Journal of biological chemistry , vol.289 , pp. 8442-8449
    • Ma, J.1    Tang, X.2    Wong, P.3    Jacobs, B.4    Borden, E.C.5    Bedogni, B.6
  • 99
    • 77954939848 scopus 로고    scopus 로고
    • MMP13 mediates cell cycle progression in melanocytes and melanoma cells: in vitro studies of migration and proliferation
    • Meierjohann S, Hufnagel A, Wende E, Kleinschmidt MA, Wolf K, Friedl P, et al. MMP13 mediates cell cycle progression in melanocytes and melanoma cells: in vitro studies of migration and proliferation. Molecular cancer. 2010; 9: 201.
    • (2010) Molecular cancer , vol.9 , pp. 201
    • Meierjohann, S.1    Hufnagel, A.2    Wende, E.3    Kleinschmidt, M.A.4    Wolf, K.5    Friedl, P.6
  • 100
    • 0037318082 scopus 로고    scopus 로고
    • Fibroblast Activation Protein: Differential Expression and Serine Protease Activity in Reactive Stromal Fibroblasts of Melanocytic Skin Tumors
    • Huber MA, Kraut N, Park JE, Schubert RD, Rettig WJ, Peter RU, et al. Fibroblast Activation Protein: Differential Expression and Serine Protease Activity in Reactive Stromal Fibroblasts of Melanocytic Skin Tumors. J Investig Dermatol. 2003; 120: 182-8.
    • (2003) J Investig Dermatol , vol.120 , pp. 182-188
    • Huber, M.A.1    Kraut, N.2    Park, J.E.3    Schubert, R.D.4    Rettig, W.J.5    Peter, R.U.6
  • 101
    • 84863116741 scopus 로고    scopus 로고
    • Fibroblast activation protein: A potential therapeutic target in cancer
    • Liu R, Li H, Liu L, Yu J, Ren X. Fibroblast activation protein: A potential therapeutic target in cancer. Cancer Biol Ther. 2012; 13: 123-9.
    • (2012) Cancer Biol Ther , vol.13 , pp. 123-129
    • Liu, R.1    Li, H.2    Liu, L.3    Yu, J.4    Ren, X.5
  • 102
    • 79956004586 scopus 로고    scopus 로고
    • Ultraviolet exposure of melanoma cells induces fibroblast activation protein-alpha in fibroblasts: Implications for melanoma invasion
    • Waster P, Rosdahl I, Gilmore BF, Seifert O. Ultraviolet exposure of melanoma cells induces fibroblast activation protein-alpha in fibroblasts: Implications for melanoma invasion. International journal of oncology. 2011; 39: 193-202.
    • (2011) International journal of oncology , vol.39 , pp. 193-202
    • Waster, P.1    Rosdahl, I.2    Gilmore, B.F.3    Seifert, O.4
  • 103
    • 84947756081 scopus 로고    scopus 로고
    • Modulating the Tumor Microenvironment
    • Gajewski TF, Hodi FS, editors. Springer New York
    • Ruby C, Kaufman H. Modulating the Tumor Microenvironment. In: Gajewski TF, Hodi FS, editors. Targeted Therapeutics in Melanoma. Springer New York; 2012: 353-69.
    • (2012) Targeted Therapeutics in Melanoma , pp. 353-369
    • Ruby, C.1    Kaufman, H.2
  • 104
    • 84864039745 scopus 로고    scopus 로고
    • Stromal fibroblasts synergize with hypoxic oxidative stress to enhance melanoma aggressiveness
    • Comito G, Giannoni E, Di Gennaro P, Segura CP, Gerlini G, Chiarugi P. Stromal fibroblasts synergize with hypoxic oxidative stress to enhance melanoma aggressiveness. Cancer letters. 2012; 324: 31-41.
    • (2012) Cancer letters , vol.324 , pp. 31-41
    • Comito, G.1    Giannoni, E.2    Di Gennaro, P.3    Segura, C.P.4    Gerlini, G.5    Chiarugi, P.6
  • 105
    • 84871021675 scopus 로고    scopus 로고
    • Mitochondrial Oxidative Stress due to Complex I Dysfunction Promotes Fibroblast Activation and Melanoma Cell Invasiveness
    • Taddei ML, Giannoni E, Raugei G, Scacco S, Sardanelli AM, Papa S, et al. Mitochondrial Oxidative Stress due to Complex I Dysfunction Promotes Fibroblast Activation and Melanoma Cell Invasiveness. Journal of Signal Transduction. 2012; 2012: 10.
    • (2012) Journal of Signal Transduction , vol.2012 , pp. 10
    • Taddei, M.L.1    Giannoni, E.2    Raugei, G.3    Scacco, S.4    Sardanelli, A.M.5    Papa, S.6
  • 106
    • 62249130824 scopus 로고    scopus 로고
    • The good and the bad of chemokines/chemokine receptors in melanoma
    • Richmond A, Yang J, Su Y. The good and the bad of chemokines/chemokine receptors in melanoma. Pigment cell & melanoma research. 2009; 22: 175-86.
    • (2009) Pigment cell & melanoma research , vol.22 , pp. 175-186
    • Richmond, A.1    Yang, J.2    Su, Y.3
  • 107
    • 78649637459 scopus 로고    scopus 로고
    • Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancy
    • Mishra P, Banerjee D, Ben-Baruch A. Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancy. J Leukocyte Biol. 2011; 89: 31-9.
    • (2011) J Leukocyte Biol , vol.89 , pp. 31-39
    • Mishra, P.1    Banerjee, D.2    Ben-Baruch, A.3
  • 109
    • 0037115647 scopus 로고    scopus 로고
    • Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells
    • Murakami T, Maki W, Cardones AR, Fang H, Tun Kyi A, Nestle FO, et al. Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells. Cancer Res. 2002; 62: 7328-34.
    • (2002) Cancer Res , vol.62 , pp. 7328-7334
    • Murakami, T.1    Maki, W.2    Cardones, A.R.3    Fang, H.4    Tun Kyi, A.5    Nestle, F.O.6
  • 111
    • 84947785158 scopus 로고    scopus 로고
    • Melanoma associated fibroblasts promote melanoma invasiveness: Possible cross talk between CXCR4 and VEGF receptor
    • Giuliano P, Jr., Ierano C, Ascierto PA, Napolitano M, Lombardi M, Liguori M, et al. Melanoma associated fibroblasts promote melanoma invasiveness: Possible cross talk between CXCR4 and VEGF receptor. AACR Meeting Abstracts. 2006; 2006: 42-b.
    • (2006) AACR Meeting Abstracts , vol.2006 , pp. 42-b
    • Giuliano, P.1    Ierano, C.2    Ascierto, P.A.3    Napolitano, M.4    Lombardi, M.5    Liguori, M.6
  • 112
    • 0142188716 scopus 로고    scopus 로고
    • CXCR4 enhances adhesion of B16 tumor cells to endothelial cells in vitro and in vivo via beta(1) integrin
    • Cardones AR, Murakami T, Hwang ST. CXCR4 enhances adhesion of B16 tumor cells to endothelial cells in vitro and in vivo via beta(1) integrin. Cancer Res. 2003; 63: 6751-7.
    • (2003) Cancer Res , vol.63 , pp. 6751-6757
    • Cardones, A.R.1    Murakami, T.2    Hwang, S.T.3
  • 114
    • 84869226562 scopus 로고    scopus 로고
    • A locked, dimeric CXCL12 variant effectively inhibits pulmonary metastasis of CXCR4-expressing melanoma cells due to enhanced serum stability
    • Takekoshi T, Ziarek JJ, Volkman BF, Hwang ST. A locked, dimeric CXCL12 variant effectively inhibits pulmonary metastasis of CXCR4-expressing melanoma cells due to enhanced serum stability. Molecular cancer therapeutics. 2012; 11: 2516-25.
    • (2012) Molecular cancer therapeutics , vol.11 , pp. 2516-2525
    • Takekoshi, T.1    Ziarek, J.J.2    Volkman, B.F.3    Hwang, S.T.4
  • 115
    • 20144368873 scopus 로고    scopus 로고
    • Gene Expression Profiling Reveals Cross-talk between Melanoma and Fibroblasts: Implications for Host-Tumor Interactions in Metastasis
    • Gallagher PG, Bao Y, Prorock A, Zigrino P, Nischt R, Politi V, et al. Gene Expression Profiling Reveals Cross-talk between Melanoma and Fibroblasts: Implications for Host-Tumor Interactions in Metastasis. Cancer Res. 2005; 65: 4134-46.
    • (2005) Cancer Res , vol.65 , pp. 4134-4146
    • Gallagher, P.G.1    Bao, Y.2    Prorock, A.3    Zigrino, P.4    Nischt, R.5    Politi, V.6
  • 116
    • 70349252148 scopus 로고    scopus 로고
    • The invasive potential of human melanoma cell lines correlates with their ability to alter fibroblast gene expression in vitro and the stromal microenvironment in vivo
    • Li L, Dragulev B, Zigrino P, Mauch C, Fox JW. The invasive potential of human melanoma cell lines correlates with their ability to alter fibroblast gene expression in vitro and the stromal microenvironment in vivo. International journal of cancer Journal international du cancer. 2009; 125: 1796-804.
    • (2009) International journal of cancer Journal international du cancer , vol.125 , pp. 1796-1804
    • Li, L.1    Dragulev, B.2    Zigrino, P.3    Mauch, C.4    Fox, J.W.5
  • 118
    • 84887626490 scopus 로고    scopus 로고
    • Interleukin-6-induced Twist and N-cadherin enhance melanoma cell metastasis
    • Na YR, Lee JS, Lee SJ, Seok SH. Interleukin-6-induced Twist and N-cadherin enhance melanoma cell metastasis. Melanoma research. 2013; 23: 434-43.
    • (2013) Melanoma research , vol.23 , pp. 434-443
    • Na, Y.R.1    Lee, J.S.2    Lee, S.J.3    Seok, S.H.4
  • 119
    • 44849141362 scopus 로고    scopus 로고
    • Cancer associated fibroblasts stimulated by transforming growth factor beta1 (TGF-beta 1) increase invasion rate of tumor cells: a population study
    • Casey TM, Eneman J, Crocker A, White J, Tessitore J, Stanley M, et al. Cancer associated fibroblasts stimulated by transforming growth factor beta1 (TGF-beta 1) increase invasion rate of tumor cells: a population study. Breast cancer research and treatment. 2008; 110: 39-49.
    • (2008) Breast cancer research and treatment , vol.110 , pp. 39-49
    • Casey, T.M.1    Eneman, J.2    Crocker, A.3    White, J.4    Tessitore, J.5    Stanley, M.6
  • 120
  • 121
    • 0027343406 scopus 로고
    • met and HGF-SF in normal melanocytes and melanoma cells
    • Halaban R, Rubin JS, White W. met and HGF-SF in normal melanocytes and melanoma cells. Exs. 1993; 65: 329-39.
    • (1993) Exs , vol.65 , pp. 329-339
    • Halaban, R.1    Rubin, J.S.2    White, W.3
  • 122
    • 14844334889 scopus 로고    scopus 로고
    • HGF induces fibronectin matrix synthesis in melanoma cells through MAP kinase-dependent signaling pathway and induction of Egr-1
    • Gaggioli C, Deckert M, Robert G, Abbe P, Batoz M, Ehrengruber MU, et al. HGF induces fibronectin matrix synthesis in melanoma cells through MAP kinase-dependent signaling pathway and induction of Egr-1. Oncogene. 2005; 24: 1423-33.
    • (2005) Oncogene , vol.24 , pp. 1423-1433
    • Gaggioli, C.1    Deckert, M.2    Robert, G.3    Abbe, P.4    Batoz, M.5    Ehrengruber, M.U.6
  • 123
    • 79952581666 scopus 로고    scopus 로고
    • The cadherin switch in melanoma instigated by HGF is mediated through epithelial-mesenchymal transition regulators
    • Koefinger P, Wels C, Joshi S, Damm S, Steinbauer E, Beham-Schmid C, et al. The cadherin switch in melanoma instigated by HGF is mediated through epithelial-mesenchymal transition regulators. Pigment cell & melanoma research. 2011; 24: 382-5.
    • (2011) Pigment cell & melanoma research , vol.24 , pp. 382-385
    • Koefinger, P.1    Wels, C.2    Joshi, S.3    Damm, S.4    Steinbauer, E.5    Beham-Schmid, C.6
  • 126
    • 57849117839 scopus 로고    scopus 로고
    • Tumor-Associated Fibroblasts as "Trojan Horse" Mediators of Resistance to Anti-VEGF Therapy
    • Francia G, Emmenegger U, Kerbel RS. Tumor-Associated Fibroblasts as "Trojan Horse" Mediators of Resistance to Anti-VEGF Therapy. Cancer Cell. 2009; 15: 3-5.
    • (2009) Cancer Cell , vol.15 , pp. 3-5
    • Francia, G.1    Emmenegger, U.2    Kerbel, R.S.3
  • 127
    • 84947753843 scopus 로고    scopus 로고
    • The microenvironment is the key determinant of melanoma drug resistance
    • Haass NK, Smalley KS, Herlyn M. The microenvironment is the key determinant of melanoma drug resistance. J Invest Dermatol. 2006; 126: 145.
    • (2006) J Invest Dermatol , vol.126 , pp. 145
    • Haass, N.K.1    Smalley, K.S.2    Herlyn, M.3
  • 128
    • 84865036227 scopus 로고    scopus 로고
    • Implication of Tumor Microenvironment in Chemoresistance: Tumor-Associated Stromal Cells Protect Tumor Cells from Cell Death
    • Castells M, Thibault B, Delord JP, Couderc B. Implication of Tumor Microenvironment in Chemoresistance: Tumor-Associated Stromal Cells Protect Tumor Cells from Cell Death. Int J Mol Sci. 2012; 13: 9545-71.
    • (2012) Int J Mol Sci , vol.13 , pp. 9545-9571
    • Castells, M.1    Thibault, B.2    Delord, J.P.3    Couderc, B.4
  • 130
    • 84947786963 scopus 로고    scopus 로고
    • Targeting Tumor Associated Fibroblasts Tumor Associated Fibroblasts and Chemotherapy
    • Mueller MM, Fusenig NE, editors. Springer Netherlands
    • Liao D, Reisfeld R. Targeting Tumor Associated Fibroblasts Tumor Associated Fibroblasts and Chemotherapy. In: Mueller MM, Fusenig NE, editors. Tumor-Associated Fibroblasts and their Matrix. Springer Netherlands; 2011: 403-18.
    • (2011) Tumor-Associated Fibroblasts and their Matrix , pp. 403-418
    • Liao, D.1    Reisfeld, R.2
  • 131
    • 33745837774 scopus 로고    scopus 로고
    • Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake
    • Loeffler M, Kruger JA, Niethammer AG, Reisfeld RA. Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake. Journal of Clinical Investigation. 2006; 116: 1955-62.
    • (2006) Journal of Clinical Investigation , vol.116 , pp. 1955-1962
    • Loeffler, M.1    Kruger, J.A.2    Niethammer, A.G.3    Reisfeld, R.A.4
  • 132
    • 79953198272 scopus 로고    scopus 로고
    • The disintegrin-like and cysteine-rich domains of ADAM-9 mediate interactions between melanoma cells and fibroblasts
    • Zigrino P, Nischt R, Mauch C. The disintegrin-like and cysteine-rich domains of ADAM-9 mediate interactions between melanoma cells and fibroblasts. The Journal of biological chemistry. 2011; 286: 6801-7.
    • (2011) The Journal of biological chemistry , vol.286 , pp. 6801-6807
    • Zigrino, P.1    Nischt, R.2    Mauch, C.3
  • 134
    • 75849116069 scopus 로고    scopus 로고
    • Molecular biology of cancer-associated fibroblasts: Can these cells be targeted in anti-cancer therapy?
    • Gonda TA, Varro A, Wang TC, Tycko B. Molecular biology of cancer-associated fibroblasts: Can these cells be targeted in anti-cancer therapy? Seminars in cell & developmental biology. 2010; 21: 2-10.
    • (2010) Seminars in cell & developmental biology , vol.21 , pp. 2-10
    • Gonda, T.A.1    Varro, A.2    Wang, T.C.3    Tycko, B.4
  • 135
    • 77951233373 scopus 로고    scopus 로고
    • Cancer associated fibroblasts (CAFs) in tumor microenvironment
    • Xing F, Saidou J, Watabe K. Cancer associated fibroblasts (CAFs) in tumor microenvironment. Front Biosci (Landmark Ed). 2010; 15: 166-79.
    • (2010) Front Biosci (Landmark Ed) , vol.15 , pp. 166-179
    • Xing, F.1    Saidou, J.2    Watabe, K.3
  • 136
    • 84875234222 scopus 로고    scopus 로고
    • Carcinoma-associated fibroblasts are a promising therapeutic target
    • Togo S, Polanska UM, Horimoto Y, Orimo A. Carcinoma-associated fibroblasts are a promising therapeutic target. Cancers. 2013; 5: 149-69.
    • (2013) Cancers , vol.5 , pp. 149-169
    • Togo, S.1    Polanska, U.M.2    Horimoto, Y.3    Orimo, A.4
  • 137
    • 84862001701 scopus 로고    scopus 로고
    • Inhibition of Fibroblast Growth by Notch1 Signaling Is Mediated by Induction of Wnt11-Dependent WISP-1
    • Liu ZJ, Li Y, Tan YR, Xiao M, Zhang JL, Radtke F, et al. Inhibition of Fibroblast Growth by Notch1 Signaling Is Mediated by Induction of Wnt11-Dependent WISP-1. Plos One. 2012; 7.
    • (2012) Plos One , pp. 7
    • Liu, Z.J.1    Li, Y.2    Tan, Y.R.3    Xiao, M.4    Zhang, J.L.5    Radtke, F.6
  • 138
    • 28244447726 scopus 로고    scopus 로고
    • Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumor-associated fibroblasts
    • Lee J, Fassnacht M, Nair S, Boczkowski D, Gilboa E. Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumor-associated fibroblasts. Cancer Res. 2005; 65: 11156-63.
    • (2005) Cancer Res , vol.65 , pp. 11156-11163
    • Lee, J.1    Fassnacht, M.2    Nair, S.3    Boczkowski, D.4    Gilboa, E.5
  • 139
    • 38849202330 scopus 로고    scopus 로고
    • Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting
    • Pietras K, Pahler J, Bergers G, Hanahan D. Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting. Plos Med. 2008; 5: 123-38.
    • (2008) Plos Med , vol.5 , pp. 123-138
    • Pietras, K.1    Pahler, J.2    Bergers, G.3    Hanahan, D.4
  • 140
    • 84904499781 scopus 로고    scopus 로고
    • Melanoma: from melanocyte to genetic alterations and clinical options
    • Bertolotto C. Melanoma: from melanocyte to genetic alterations and clinical options. Scientifica. 2013; 2013: 635203.
    • (2013) Scientifica , vol.2013
    • Bertolotto, C.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.